2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Structural insights into the evolutionary simplification of human ClpP activators.

      1 , 2
      Structure (London, England : 1993)
      Elsevier BV

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          In this issue of Structure, Mabanglo et al. characterize five ClpP agonists termed TRs. The co-crystal structures reveal more robust shape and charge complementarities than the anti-cancer agent ONC201. These novel compounds are of potential therapeutic interest because they enhance ClpP proteolytic activity and have an inhibitory effect on tumor cell growth.

          Related collections

          Author and article information

          Journal
          Structure
          Structure (London, England : 1993)
          Elsevier BV
          1878-4186
          0969-2126
          Feb 02 2023
          : 31
          : 2
          Affiliations
          [1 ] State Key Laboratory of Drug Research, Centre for Chemical Biology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China; University of Chinese Academy of Sciences, Beijing 100049, China.
          [2 ] State Key Laboratory of Drug Research, Centre for Chemical Biology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China; University of Chinese Academy of Sciences, Beijing 100049, China; School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, China. Electronic address: yangcg@simm.ac.cn.
          Article
          S0969-2126(23)00004-7
          10.1016/j.str.2023.01.002
          36736297
          12f90e4f-5bdf-4f76-8e6c-433b4ff83f61
          History

          Comments

          Comment on this article